Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Gramatzki, Martin
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Philippen L
,
Schub N
,
Günther A
,
Cario G
,
Schrappe M
,
Repp R
,
Gramatzki M
.
Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
Bone Marrow Transplant. 2023.
PubMed
Google Scholar
Straka C
,
Liebisch P
,
Salwender H
,
Hennemann B
,
Metzner B
,
Knop S
,
Adler-Reichel S
,
Gerecke C
,
Wandt H
,
Bentz M
, et al.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica. 2016.
PubMed
Google Scholar
E
Guenther A
,
Baumann P
,
Burger R
,
Kellner C
,
Klapper W
,
Schmidmaier R
,
Gramatzki M
.
Everolimus (RAD001) Activity in Relapsed and/or Refractory Multiple Myeloma: A Phase I Study.
Haematologica. 2015.
PubMed
Google Scholar
F
Straka C
,
Salwender H
,
Knop S
,
Vogel M
,
Müller J
,
Metzner B
,
Langer C
,
Sayer H
,
Jung W
,
Dürk HA
, et al.
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Eur J Haematol. 2021.
PubMed
Google Scholar
M
Oberg H-H
,
Kellner C
,
Peipp M
,
Sebens S
,
Adam-Klages S
,
Gramatzki M
,
Kabelitz D
,
Wesch D
.
Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy.
Front Immunol. 2014;5:643.
PubMed
Google Scholar
P
Bringhen S
,
Milan A
,
D'Agostino M
,
Ferri C
,
Wäsch R
,
Gay F
,
Larocca A
,
Offidani M
,
Zweegman S
,
Terpos E
, et al.
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A Consensus Paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.
J Intern Med. 2019.
PubMed
Google Scholar
R
Kirschey S
,
Flohr T
,
Wolf HW
,
Frickhofen N
,
Gramatzki M
,
Link H
,
Basara N
,
Peter N
,
Meyer RG
,
Schmitz N
, et al.
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
Br J Haematol. 2014.
PubMed
Google Scholar
S
Kharfan-Dabaja MA
,
Labopin M
,
Brissot E
,
Kröger N
,
Finke J
,
Ciceri F
,
Deconinck E
,
Blaise D
,
Chevallier P
,
Gramatzki M
, et al.
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Br J Haematol. 2021.
PubMed
Google Scholar
Christopeit M
,
Kuss O
,
Finke J
,
Bacher U
,
Beelen DWilhelm
,
Bornhäuser M
,
Schwerdtfeger R
,
Bethge WAndreas
,
Basara N
,
Gramatzki M
, et al.
Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change.
J Clin Oncol. 2013.
PubMed
Google Scholar
T
Kellner C
,
Lutz S
,
Oberg H-H
,
Wesch D
,
Otte A
,
Diemer KJ
,
Wilcken H
,
Bauerschlag D
,
Glüer C-C
,
Wichmann C
, et al.
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.
Biol Chem. 2021.
PubMed
Google Scholar